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Differences in Human Skin Between the Epidermal Growth Factor 
Receptor Distribution Detected by EGF Binding and Monoclonal 
Antibody Recognition 
MARTIN R. GREEN , D.PHIL . AND JOHN R. COUCHMAN , PH.D. 
Biosciences Division, Unileuer Research . Colworth Laboratory, Shambrook, Bedfordshire, U. K. 
Two methods have bee n used to examine epidermal 
growth factor (EGF) receptor distribution in human 
scalp a nd foreskin. The first employed [125 l ]EGF viable 
explants a nd autoradiography to determine the EGF 
binding pattern while the second used a monoclonal 
antibody to the human EGF r eceptor to map the distri-
bution on froze n skin sections of an extracellular epitope 
on the EGF receptor. The [125l]EGF binding experiments 
showed accessible, unoccupied EGF receptors to be pres-
ent on the epidermal basal cells (with reduced binding 
to spinous cells) , the basal cells of the hair shaft and 
sebaceous gland, the eccrine sweat g lands, capillary sys-
tem, and the hair follicle outer root sheath, generally 
similar in pattern to that previously reported for full-
thickness rat skin and human epidermis. The same areas 
also bound EGF-Rl but in addition the monoclonal an-
tibod y recognized a cone of melanin containing pre-
s umptive cortex cells, excluding the m edulla, ly ing 
around and above the upper dermal papilla of anagen 
hair follicles , e pithelial cells around the lower dermal 
papilla region, and in some tissue samples the cell mar-
gins of the viable differentiating layers of the epidermis. 
In a control study, to clarify whether EGF-Rl could 
recognize molecules unrelated to the EGF receptor, the 
EGF binding a nd EGF-Rl recognition profiles were 
compared on cultures of SVK14 cells, a SV40 trans-
for med human k e r atinocyte cell line. EGF binding and 
EGF-Rl monoclonal antibody distribution on these cells 
was found to be similar, indicating that, at least for 
SVK14 cells, EGF-Rl binding provides a reliable 
marker for EGF binding. Explanations for the discrep-
ancies between these two methods for determining EGF 
receptor distribution in human skin are discussed, in-
cluding the possibility that latent EGF r eceptors, unable 
to bind (125 l ]EGF, may be present in some diffe rentiating 
epithelial compartments. 
Epidermal growth factor (EGF) is a well -cha racte rized [1- 4] 
low-M, polypeptide, first isolated fro m mouse submaxi llary 
glands [5], able to promote t he proliferation of cells of ectoder-
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BSA: bov ine serum album in 
EGF: epidermal growth factor 
FITC: ll uoresce i1; isothiocyanate 
HBSS: Hanks' balanced salt solution 
HE PES: N-2- hyd roxyethylpiperazine-N' -2-et hansulphonic ac id 
PBS: phosphate-buffered saline, Dulbecco's formulation 
PMSF: phenylmethylsulfonylchloride 
SDS: sodium dodecyl sulfate 
SFM: se rum-free medium containing 0.1 % BSA and 15 mM 
HEPES pH 7.4 
Tf-R: human transferrin receptor 
Tris: 2-amino-2( hydroxymethyl)propane-1,3-diol 
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mal [1 ,6,7], endodermal [8], and mesenchymal [1,9] origin. EGF 
binds to saturable, cell surface receptors, inducing receptor 
clusterin g, internali zation , and degradation of both EGF and 
its receptor [1 ,10- 12]. This process gives rise to receptor "down 
regu lation" [1] and eventually a lower steady state level of 
receptor number [13] when insertion of new receptors in to the 
cell membrane is balanced by normal receptor turnover and 
EGF- induced in ternali zation (1 4]. Induction of cell p roli fera-
t ion requires prolonged incubation of EGF with cells [1] suffi-
cient to a llow reestablishment of the lower steady state level of 
cell surface EGF receptors. Alt hough the precise biochemica l 
mechanisms by which mitogenesis is promoted remain unclear , 
a recent report [14] has proposed that total cell recepto r occu-
pancy after steady state condi tions are reestablished is corre-
lated with the rate of cell proli feration. 
EGF receptor sequencing data [15] and eDNA ana lysis 
[16, 17] have demonstrated a striking sequence homology be-
twee n t he cytoplasmic port ion of the EGF receptor and t he v-
erb-B t ransforming oncogene of avian erythroblastosis virus. 
Initial evidence suggests [1 7] that t he human EGF recepto r 
gene is homologous with c-erb- B, further emphasizing the 
potential importance of the EGF receptor in t he cont rol of 
normal and abnormal cell proliferation. 
Previous studies have examined the [115I]EGF binding pat-
te rn in 13-day-old mouse palatal shelves [18], full-thi ckness rat 
skin [19], embryonic rat skin development [20,21], t he rat hair 
growth cycle [21 ], and human ep idermis [22] with, as a genera l 
rule, a correlation being detected between areas of ep itheli a l 
cell prolife ration and abili ty to bind [125I]EGF. Moreover, a 
striking correlation has been detected between the basal ep i-
dermal ce ll proli feration rate in neonatal rat skin aged 1-27 
days and the number of (unoccupied) receptors detected on the 
iso lated basal cells [19], leading to the proposal t hat the steady 
state number of epidermal basa l cell EGF receptors may be 
linked to t he growth rate of the basal cells in vivo. 
We report here on t he localization of [125I]EGF binding sites 
in whole human skin , including the ep idermis, sweat gland , 
sebaceous gland, and hair fo llicle compared with t he immuno-
fluorescence pattern detected using a monoclonal ant ibody to 
the human epide rmal growth factor receptor, EGF-R1 [23]. 
Almost all areas of epithelial cell proliferation in human skin 
bind [1251] EGF, fur t her supporti ng t he potential importa nce of 
the EGF receptor and associated ligand(s) in regu lating ep ithe-
li al ce ll p roliferation. The monoclonal antibody, which is known 
to recognize occupied, unoccupied [23, t his work], pa rtially 
degraded [1 2], and precusor [24] forms of the EGF-receptors, 
recognizes all t he regions able to bind [125I]EGF, but in add it ion 
stains ep ithelial cell s surrounding the lower and upper parts of 
the hair fo llicle dermal papilla and , in some cases, ce ll margins 
in t he upper epidermal layers. Possible explanations for t he 
differences in EGF receptor distribution detected by the two 
methods a re discussed. 
MATERIALS AND METHODS 
Autoradiography 
EGF was purified from adult male mouse submaxillary glands 125 ] 
and radioiodinated using iodogen [Pierce and Warner (U. K .) Ltd. [. 
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lodogen (50 Pi:) in chloroform was dried under a st rea m of nitrogen 
onto the wa lls o f a glass via l a nd rinsed twice with phosphate-buffered 
saline (PBS, Du lbecco's formulation) . EGF (10- 20 pg) was added in 
10- 20 ,.J of distilled wate r immedi ately before the addition of 20 p] X 
double-strent;th PBS and 2 mCi carrier-free 12'' 1 (Amersba m In tern a-
t ional pic, U.K.) . The reaction was a llowed to proceed with occasional 
s hak ing for 20 min at room temperatu re a nd quenc hed by the addition 
of 10 mM Na t. The '2''1 -labeled EGF was desalted on a Sephadex G25 
column (1.4 X 5 em) equilibrated with l mg/ml bovine se rum album in 
(BSA) in PBS and had a typica l sp ac t. of 100- 200 ~~ C i /p g EGF. The 
bindin g profile of \' 2'' 11 EG F in skin was determined by incubating 6 nM 
[ 12"1 [ EGF with viab le human s kin exp la nt s (-0.3 X 0.6 mm) in Ha nks' 
bal anced sa lt solu tion (HBSS) co nta ining 15 mM N -2- hydroxyethyl-
piperazin e-N '-2-et hanesulfonic ac id (HE PES) pH 7.3 a nd 1 mg/m l 
BSA for 90 min at 25· c. followed by fix ation a nd processing for 
autoradiography, as prev iously desc ribed \1 9,2 1]. Autoradiographs were 
exposed for 3- 8 wee ks. 
Jm.munofluorescen.ce of S hin 
Frozen sections (5 pm) of eit her human scalp skin or foreskin were 
cut onto glass l' lides a nd all owed to a ir dry. In some expe riments, to 
improve histologic preservation, sections were fi xed for 10 min in 
ethanol a t 4 · c a nd redried. T his treatment had no effect on a ntibody 
staining. Sections we re covered wit h a 5% solution of BSA in PBS for 
15 min to reduce nonspec ific binding before incubation for 1 h at 37•c 
in a wet box with 20 pg/ml EGF-R1, a monoclonal a ntibody to the 
human EGF receptor [23 \ (the kind gi ft of Dr. M. W aterfield, Imperial 
Cance r Resea rch Fund , Lin coln 's Inn Fields, London). The sections 
we re extensively washed with PBS for 45 min before incubat ion with 
a 1:15 dilution of lluoresce in isoth iocyanate (F ITC) labeled goat anti -
mouse lg a ntibody (Hybridoma Sciences, Atlanta, Georgia) for 30 min 
at room temperature. Sections we re washed a nd mounted in 0. 1% 
paraphenyla minediam ine in 90% glyce rol to reduce lluoroscence pho-
tobleaching !26 \. 
Tissues 
Huma n neo nata l fores kin was sto red at 4· c in HBSS following 
surgica l removal and used the same day for \125l]EGF binding studies. 
For immunolluorescence studies, t issue was snap-frozen in liquid ni -
trogen and stored a t -8o· c until use. Human scalp skin biopsies, 
obtained follow ing ha ir t ransp la nt surgery (B iogra ft Medical Group, 
Tamworth , U.K.) were t reated in a s imilar fashion. 
S'V/<14 Cells 
SVK14 cell s \27 1, a n SV40 tra nsformed human kerati nocyte ce ll 
lin e, were obtained from Dr .. J. Taylor-Papadimitriou (Imperial Cance r 
Resea rch Fund , Lincoln 's Inn Fields, London) a nd ma intai ned in 
RPM! 1640 medium supplemented with 10% fetal ca lf se rum , 50 ng/ 
ml cholera tox in , a nd 5 pg/ml hydrocortiso ne. Cells were spli t 1:12 
twice per week using 0.05 % w/v t.rypsin:0.02% EDTA and used at 
passages 18- :10. For lluorescence studies SVI<J 4 cells we re seeded at 
150,000 ce ll s per 22 mm -d iamete r cove rslip a nd cultured for 2 days to 
obtain high-density cultures. 
Cells were incubated with the primary a ntibody or ligand at 4•c for 
1 h in serum -free med ium conta ining 0.1 % BSA and 15 mM HEPES 
buffer pH 7.4 (SFM ) before being washed in SFM at 4 ·c for 45 min , 
fi xed with :t5% pa ra formaldehyde at 4•c for 15 min , a nd incubated at 
room temperature for a furt her l fi min with 0.1 M am monium chloride 
to chemically reduce free aldehyde groups. Subsequent antibody i ncu-
hat ions were in PBS conta ining O. J % BSA for 30 min a t room temper-
ature fo llowed bv an extensive wash for 30 min in PBS. EGF-Rl was 
used at 50 pg/m,l in conjunction with either a rhodamine- or fluores-
ce nce- labeled goat antimouse lg antibody (Hybridoma Sciences). EGF 
binding sites were determined usin g mouse EGF coupled to FITC at I 
~~ g/ml followed by a 1:50 dilution of a rabb it a nti-FITC an tibody (both 
ite ms t he kind gill of Dr. M. Geisow, Nationa l Inst itute of Medical 
Resea rch, Mi ll Hill , London) a nd a 1:50 dilu tion of FITC- labeled goat 
a nt irabbit lgG antibody (Mi lel' -Yeda). Dual fluorescence studies were 
ca rried out by incubatin g SVK 14 cells wit h a mixture of EGF -Rl and 
FITC- EGF at 4•c fo llowed by fi xation a nd sequentia l incubat ion with 
the following a ntibodies: RITC-goat antimouse- lg a ntibody, rabbit 
a nt i-FITC ant ibody, FITC-goat a nt i rabbit a ntibody. Approp riate con-
t rols were ca rried out to check for nonspecific binding a nd included 
omission of one or both lluoresce nt a ntibodies, omission of one or both 
primary antibody a nd/o r liga nd, a nd addi t ion of a JOO-fo ld excess of 
unlabeled EGF to the FITC-EGF conjuga te. 
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S pecificity of EGF-R I Antibody 
To confirm t he specificity of EGF-R1 binding to SVKI4 cells , the 
antibody was used to immunoprecipitate a ntigens from 1251 surface-
labeled SVKI4 cells. This was compa red wi th EGF-R1 immun oprecip-
itated EGF receptor, the receptor having bee n unambiguously identified 
by cross- linking to \125 l]EGF. For the labeling ex periments SVK14 cells 
were subcultured at a ratio of 1:6 onto 80-cm2 plast ic bottles and used 
after 48 h as the cu ltures app roached conlluency. Cell surfaces were 
labeled with 125I using the lactoperoxidase/glucose ox idase method 
!28]. Bottles of cells were washed 3 times in PBS, drained, and 1 ml of 
10 mM glucose in PBS added followed by 0.5 mCi of carrier-free 1251 
(Amersha m In te rnational pic ), 60 mg of lactope roxidase (Sigma) in 60 
pi of PBS, a nd 0.2 uni ts of glucose oxidase (Boehringer Man nheim). 
The reaction was allowed to proceed for 15 min with occasional swirling 
before t he ce lls were washed 3 times with PBS containin g 5 mM Nal 
and 2 mM phenylmethylsulfonylchloride (PMSF) and lysed wi th 5 ml 
of O.Ql M 2-amino-2(hydroxymethyl)propane-1,3-diol (Tris) buffer pH 
8.0 conta ining 0.4 M sodium chloride , 0.5 mM EDTA, 0.02% sodium 
azide, l % Nonidet P-40, 2 mM PMSF, a nd 5 mM N-ethylmaleimide 
(lys is buffer). Afte r 15 min, 5 ml of 0.01 M Tris pH 8 buffer, conta ining 
0.15 M sodium ch loride, 5 mM EDTA, 0.02% sodium azide, and 1% 
Nonidet P40 (immunoprec ipi tat ion buffer) was added and the lysate 
passed through a 0.2-pm fil te r. For immunoprec ipitations, 20 pg of 
EGF-Rl or 20 pi of control a nt ibody was tumble- mixed fo r l'h h at 
room temperature with app roximate ly 2 mg of protein A conjugated to 
Sepharose (Pha rmacia), washed twice, and tumble-mixed for a further 
1'12 h with 1 ml of cell lysate. The protein A-Sepharose was t hen washed 
3 t imes with immunoprecipita t ion buffer and once in 0.01 M Tris buffe r 
pH 8.0 before addition of sample buffer conta ining 2% sodium dodecyl 
sulfate (SDS) and 2% mercaptoethanol a nd SDS gel elec trophoresis on 
3-15% polyac rylamide gradient s lab gels wi th a 3% stacking gel using 
the method of Blobel and Dobberstein \29]. A polyclo nal antibody to 
the huma n transferrin receptor (Tf-R) (the kind gift of Dr. J. Bliel, 
Laborato ry of Molecula r Biology, Medical Resea rch Council Centre. 
Hills Road, Cambridge) was used as a cont rol. The EGF receptor was 
labeled as fo llows by sponta neous cross- linking to [1251]EGF [30] pre-
pared by the chloram ine T method [19]. Bottles of SVK14 cells were 
washed twice at o·c with SFM and incubated for 70 min at o· c with 
40 ng/ml [125I]EG F in SFM containing, if appropriate for control 
purposes, 2 pg of unlabeled EGF. The cells were washed 3 t imes in cold 
SFM a nd twice in cold PBS before lysis a nd immunoprecipitation with 
EGF-Rl as described above. 
F IG 1. Distribution of labe l follow ing incubation of human scalp 
skin (a and b) and foreskin (c and d) with 6 nM [125 l]EGF. Bright-field 
illumination is used to display the section on the left a nd in terference-
refl ection optics to hi ghlight t he s ilver grains on the right. The silver 
grain pattern shows the localization of unoccupied, accessible EGF 
receptors. Label is restricted ma inly to the basal ce ll a nd rete peg areas 
with a dec reasing gradation of label on passing from basal to spinous 
ce lls. In (a) and (b) some nonspecific binding to the surface of the 
stratum co rneum can be seen. Scale bars= 10 pm. 
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Microscopy 
P hotographs were ta ken using a Leit z Ortholu x ll microscope 
equipped with epi -illuminat ion, a Ploe m flu orescence vertica l illumi · 
nator and phase contrast , flu orescence, and in te rfe rence- refl ection 
objectives on II fo rd XPl or Kodak Ectac hrome 400 film . 
RESULTS 
[1 25 I] EGF Binding Distribution in Human Shin 
The distribution of accessibl e, unocc upied EGF receptors in 
v iable human s kin , detected by [125I] EGF bind ing and a utora-
diography is s hown in Figs 1 a nd 2. Receptors a re detected on 
t he ep idermal basal ce ll s o f huma n scalp (Fig 1a,b) a nd foreskin 
(Fig 1c,d) with a redu cing gradation of label moving away fro m 
t he basal cell s, over t he sp inous cell laye rs, compa ra ble in 
pattern to t hat previous ly reported for huma n [22 ) and rat [19] 
epidermis. No labe ling above bac kground is seen if incubations 
a re done in t he presence of a la rge excess of unl abeled EGF 
(not s how n) as previously reported [19 ,2 1]. Evidence of en -
hanced binding of EGF to t he basal 2 or 3 cell layers within 
rete pegs compa red with othe r basal epidermal basa l cells is 
a lso appa rent (Fig 1a,b). EGF binding is seen ove r t he outer 
s h eath of t he uppe r ha ir s ha ft, arrector p ill muscles (not 
F tc 2. Human sca lp skin showing EGF receptor distribut ion dis-
played as described in Fig l. a and b, Sebaceous gland with the majori ty 
of label restricted to the undifferent iatE:d sebocytes. c and d , Ecc rine 
sweat gland labeling. Enhanced binding is seen ove r the duct. compared 
with the sec retory component of the gland. A rrows point to a small 
blood vesse l which is poorly labeled. e and[, Composite photograph of 
a matu re, anage n hair folli cle showin g EGF receptors over the outer 
root sheath and, to a much lesser extent, over the basal, undifferen-
t iated epi thelial ce ll s around the de rmal pap illa. Sca le bars= 10 11111. 
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s hown) , a nd sebocytes proximal to t he basement membran e 
zo ne (Fig 2a,b) . The eccrine sweat glands (Fig 2c,d) have EGF 
recepto rs with t he labeling of t he double- layered ducta l ep it he-
lium being pa r t icularly prominent in comparison to the secre-
tory tubules . Enhanced binding of [125l]EGF t o t he cells of t he 
a nagen ha ir fo llicle oute r root s heath is observed (Fig 2e,f), 
weak labeling is seen on t he epit he li a l cells surrounding t he 
de rmal papilla, while the dermal papilla itself in unlabeled (Fig 
2e,f). The capillary system appears only to bind a low level of 
[ 125I)EGF (arrows, Fig 2c,d). 
EGF-Rl Recognition of Skin 
Indirect immunofluorescence staining of human scalp skin 
and foreskin epidermis with EGF-R1 a n t ibody is shown in Fig 
3. The a n t ibody recogni zes t he basal and spinous cell a reas on 
both t issues (Fig 3a,b) but, in additio n, in nea rly a ll t issue 
samples there is recognit ion of a ll t he viable upper epide rmal 
Ftc 3. Indirect immunofluorescence micrographs of EGF-Rl stain-
ing on human epidermis. a, Scalp skin epidermis, showin g recogni t ion 
of the cell margins of all the viable layers of the epidermis wi t.h slight ly 
less in tense staining of the upper layers. In cont rast, mainly basal/ 
spinous cell labeling is seen with [125I]EGF (see Fig l c,d) . b, Foreskin 
epidermis, again showing recogni tion of all t he viable epide rmal layers. 
c, Co ntrol scalp skin epidermis, sta ined with second antibody alone. d, 
Sca lp skin dermis, showin g recogni tion of the eccrine sweat duct with 
much weaker sta ining of the secretory tubules. The punctate pattern 
in the tubules arises from autonuorescence. T he [125 l) EGF binding 
distributio n (see Fig 2c,d ) agrees well with this pattern. e, Scalp skin 
dermis, showing sebaceous gland immunoflu orescence with recognition 
mainly of basa l sebocyt.es. Scale bars= 10 11 m. 
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cell laye rs, t hough of reduced in tensity (F ig 3a,b). Simila r 
staining patterns were seen using 2 separate batc hes of antibody 
purilied from ascites fluid showing that thi s observation was 
not due to endoge nous mouse ant ibody present in EGF-Rl 
copurilied from ascites flui d. No sta ining was seen using a 
cont rol lgG2~, ant ibody hav ing t he same ant ibody class as EGF-
Rl [23) (not shown ). Suffi cient purifi ed EGF receptor was not 
ava ilable to permit ant igen absorpt ion controls though t he 
antibody was found to be monospec i(ic by immunoprecipi tation 
(see below). No staining other t han an occasional weak recog-
ni t ion of the stratum corneum was seen using t he f1u orescently 
labeled second antibody a lone (Fig 3c). 
T he monoclonal ant ibody a lso binds the basal ce ll s of t he 
uppe r hair sha lt (not shown ), eccrine sweat glands (Fig 3d ), 
undifferentiated sebocytes prox imal to the base ment membrane 
(Fig 3e ), and t he oute r root sheath of t he ha ir foll icles (Fig 4a) 
in good agreement wi th the [' 2' l]EGF binding profil es. Dermal 
fibroblasts, which bind only very low leve ls of [125l] EGF [19] 
were, within the limi ts of detection, very weakly stained or not 
s tained at a ll by EGF-Rl. In addition, however, EGF-R1 rec-
ogni zes (a) t he ma rgins of cell s in a p roliferating epit helial 
compart ment prox imal to the basement membrane zone lying 
around the lower dermal pap illa of anagen fo llicles (Fig 4a), 
and (b) a cone of melanin conta ining, matrix ce ll s, excluding 
t he medull a (not shown), destined to form t he bulk of t he ha ir 
shaft lying a round the top one-thi rd to one- half of the dermal 
papilla and extending seve ral cell laye rs away from t he sides, 
and above t he ti p, of t he dermal pap illa (Fig 4b ) . 
Inte restingly the cells recognized by EGF-Rl around the top 
ha lf of t he de rmal papi lla were generally not clear ly delineated 
F1c: 4. Imm unoflu orescence micrographs showing EGF -RJ recog-
ni t ion in the lower ha ir bu lb (a) , a nd a n a rea in t he upper ha ir bulb 
ru nnin R arou nd and above t he Lip of the de rma l pap illa (b) . a, Bri ght 
ll uoresce nce ca n he seen on t he basa l ce lls o f t he oute r root sheath a nd 
ce lls a round the lowe r de rm al pap il la. b, Cellula r outlines a re clearly 
vis ib le togethe r with so me tine pun ctate sta inin g implying int race llula r 
recogni t ion. Arrows illust rate a reas of relative ly sha rp and d iffuse sta in . 
T he tip oft he dermal pap illa lies a t t he bottom right -ha nd corne r o f 
the microg raph a nd the stained oute r root sheath lies on t he left-hand 
s ide of t he picture . c and d , Double immunoflu oresce nce labe lin g of 
SVK 14 ce lls show in g EC:F recepto rs detec ted us ing EG F-FIT C a nd 
EGF-R l recognit ion, respec t ive ly. S cale ba rs= 10 pm. 
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(Fig 4b) wi th a wispy or occasiona lly a fine punctate stain in 
the a rea of t he cell margins. Two arrows (Fig 4b ) point to 
firstly, a sharp, presumably cell membrane structure and, sec-
ondly, a representative area of diffuse stain . T hese data suggest 
that the immunoreactive EGF receptor in this region of the 
ha ir follicle is not uniformly restricted to the ce ll membrane. 
S VK1 4 Cells 
Given that t here was some disparity between [125l) EGF bind-
ing and EGF-Rl recognit ion in human skin as shown above, 
we examined t hese two paramete rs by double fluorescence on 
SVK14 cells, a SV40 t ransformed human keratinocyte cell line 
[27]. SVK14 cells appea r to have unlimited growt h potent ial 
[27], but have retained a number of "epidermal-like" properties 
[31] though they express an abnormally high number of recep-
tors for EGF (32] (0 .6 x 106 receptors per ce ll , M. R. Green, 
unpublished). The EGF binding and EGF -R1 distribut ions on 
live SVK14 cells at 4 oc were detected as desc ribed in Materials 
and M ethods. Fig 4c shows t he EGF binding profil e of a typical 
fi eld of SVK14 cells at high density labeled with the EGF-
FITC conjugate. The EGF-Rl localization (Fig 4d) and EGF-
FITC binding profi les (Fig 4c) are simila r, indicating that, as 
might be expected, on the surface of SVK14 cell s EGF-Rl 
recognition parallels EGF binding. Inclusion of unlabeled EGF 
wit h EGF-Rl reduced FITC-EGF labeling to background levels 
(not shown) but did not a ffect t he EGF -R l binding pattern at 
4 oc (not shown) indicating, as has been previously reported 
(1 2,23 ], t hat EGF-R1 can bind occupied receptors. Appropriate 
cont rols were carried out to test for nonspecific binding (see 
Materials and M ethods) and proved satisfactory, t hough a weak, 
diffu se bac kground stain was detected using the rabbit anti-
FITC ant ibody. 
S pecificity of B ind ing of EGF-Rl to SVK1 4 Cells 
As a further cont rol, to ensure t hat EGF-R l had sole spec i-
ficity for the EGF receptor on a human epidermal cell line, the 
ant ibody was used to immunoprecipi tate the EGF receptor, 
cross- linked to [125l)EGF, from SVK14 ce lls (Fig 5, t rack a) and 
compared wi th the proteins immunoprecipi tated from the total 
complement of 1251-labeled cell surface prote ins (Fig 5, track d) . 
T rack a shows that EGF-Rl immunoprecipitates a polypeptide 
corresponding to t he EGF receptor and t rach d indicates that 
t his is t he only cell surface protein brought down by the 
150-
90-
a b c d e 
FI G 5. Polyac rylamide 3- 15% gel e lectrophores is of S VK14 immu-
nop recipitates. Trachs a-c , Cells labeled by incubation with [125l] EGF 
prepa red us ing t he ch lo ramine T met hod. T rachs d and e, Cells su rface 
labeled with ' 2' ! us ing t he lactoperoxidase method. T racll a, EGF-Rl 
immunoprec ipi tate. T racl; b, As trach a wit h 2 pg/ml unlabeled EGF 
included dur ing 1 115 l] EG F cross- linking procedure. Trach c, Ant i- t rans-
ferrin -recepto r a nt ibody immunoprec ipi tate . Trach d, EG F -Rl immu-
noprecipi tate , Trach e, Ant i-t ra nsfer rin -recepto r an t ibody immunopre-
cip itate. T he M, of t he im munoprecip itated EG F and tra nsferrin 
recepto rs a re J50K and 90K, respect ive ly. 
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a n t ibody in agreement with previously reported data using 
A43 1 ce lls [23]. The weaker band running 20 kilodaltons below 
the EGF recepto r is most probably generated by the action of 
an intracellular ca lcium-dependent protease [33]. We find, that 
on 3-15% gradient polyacrylamide slab gels, t he EGF receptor 
migrates with a n M, of 150K but with an M, of 180K on a 
nongradient gel (not shown) . Tra.chs b, c, and e are controls 
showing, respectively, t he immunoprec ipation by EGF-Rl of 
the EGF recepto r cross- lin ked to [' 2''1]EGF in the presence of 
a 2 J.Lg/ml unlabe led EGF, immunoprecipitat ion of t he Tf-R 
from ce ll surfaces exposed to [125I]EGF, and immunoprecipita-
tion of t he Tf-R with an M, of 90K from 1 ~5 1 surface -labeled 
SVK14 ce ll s. 
DISCUSSIO N 
S ince t he completion of t hi s work Nanney et a ] (34] have 
described the 1 ~5 I -binding profile and t he recognition profi le of 
a polyclona l ant i-EGF- recepto r ant ibody in human skin . Their 
histologic data a re broadly simila r to those reported here t hough 
our studies on t he ha ir follicl e are more extensive. This paper, 
however, clea rly points to t he presence of latent immunoreac-
t ive EGF recepto rs in normal human skin which are unable to 
bin d (12"I]EGF. Possible exp lanations for the nature of t hese 
latent recepto rs a re discussed below. 
T he two methods used he re to recognize EGF receptors wi ll 
detect sepa rate recepto r pools. Firstly, incubations of [125l]EGF 
with viable skin exp lants will loca lize unoccupied , accessible, 
cell su rface EGF receptors. Tn addi t ion, binding of EGF to ce ll s 
in cul ture [1] and t issues [35 ] stimulates receptor cluste ring 
a nd internali zation and so a proportion of the label observed 
on the auto rad iographs will a ri se from interna lized ligand. 
Indeed our electron microscope autoradiograph obse rvat ions 
suggest that EGF is processed in a conventiona l manner [36] 
in t he epidermal and ha ir follicle epithelia l cell s of rat skin [37, 
and work in preparation]. EGF-R1 is known to bind a polypep-
tide site on t he extrace llula r domain of t he EGF recepto r (23] 
and is able to recognize nascent [24], ce ll surface [12,23, this 
work], and in te rnali zed, pa rt ly degraded [12] forms of t he 
receptor. Therefore immunof1u orescence studies on frozen sec-
tions of sk in will detect the steady state distribut ion of cell 
surface and intracell ular recepto rs in t he absence of any a rti -
ficia l stimulus promoting recepto r in te rnali zation. 
The binding profi le for [ 1 ~'' TJ EGF to human sca lp (Fig l a,b) 
and foreskin (F ig lc,d) epidermis shows t hat the highest level 
of EGF binding is to the epidermal basa l ce lls, wi t h reduced 
bindi ng to spinous ce ll s and practica ll:• no binding to the 
uppermost viable layers of the epidermis. The pattern is simila r 
to t hat previously reported for human epidermis [22] and is 
sim ilar, but not identica l, to t hat obse rved with rat sk in [19] 
where a much more abrupt dec rease in EGF receptors is seen 
in sp inous compared to basa l cells. T ncreased label is seen ove r 
t he basa l 2 or 3 ce ll layers in rete pegs compared with shallower 
epidermal a reas (arrows Fig la- d) which could be pa rt ially 
accounted for by the increased ce llulari ty in t hese a reas, but 
may also relate to the enhanced ['1H] t hymidine labe ling index 
found for the same rete pegs regions when compared with 
shallow epidermis [38]. Interestin gly, it has previously been 
s hown t hat in neonata l rats t he ep idermal basal cell prolifera-
tion rate is co rrelated with (unoccupied) EGF receptor number 
[19] and the enhanced number of EGF receptors detected here 
ove r the lower rete pegs is ent irely consistent with this obser-
vation. 
T he [1""T]EGF binding to t he other components of skin is 
restri cted to the basal sebocytes (Fig 2a,h), swea t glands, pa r-
ticu la rly the ducta l port ion, (Fig 2c,d), and outer root sheath 
of t he hai r bu lb and shaft (F ig 2e,() . Weaker labe ling is seen 
over t he capillary system (a rrows, Fig 2c,d) and a rrecto r pili 
musc le (not shown). No labeling is see n over t he ha ir folli cle 
dermal papi ll a fibrob lasts (Fig 2e,f) (see [21] for a discuss ion ) 
and a much reduced number of recepto rs is detected on the 
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basal epithelia l cells surrounding t he dermal papilla (Fig 2e,f) 
as reported for rat skin [19 ,21]. 
EGF-Rl recognizes all the components of human sca lp skin 
and foreskin t hat are able to bind (125I]EGF (Figs 3, 4a,b) and, 
as expected, recognizes mainly the margins of the epit helia l 
cells. However, in addition, EGF-Rl stains the upper differen-
tiated epidermal cell layers in most tissue samples (Fig 3a,b ), 
the basement membrane region and cell margins in a prolifer-
ating epitheli al compartment around t he lower dermal papilla 
(Fig 4a), and a cone of differentiati ng, epithelial cells around 
and above t he upper dermal papilla region (Fig 4b ). The stain-
ing of the epi t helial ce lls a round the lower dermal papilla region 
(Fig 4a) appea rs to be part ia lly polarized to the surface abutting 
the dermal papilla, suggesting that EGF receptors in thi s a rea 
are more abundant on th is surface opposed to t he dermal 
papi lla . Gusterson eta] [39] have also used EGF-Rl to examine 
the distribu t ion of the EGF receptor, in a wide range of normal 
human tissues and some tumors. They find, in agreement with 
our studies on skin , t hat the monoclona l ant ibody recognizes 
mainly t he proli ferating epithelial compartments and in some 
tissues, areas of epi thelial differentiation . 
There is a range of, or combination of, explanations which 
may account for the wider EGF-R1 staining when compared to 
( 12"I]EGF binding in skin. Firstly the monoclonal antibody may 
ident ify receptors for EGF which a re inaccessible to [' 25I]EGF 
because of inadequate penetration of t he radiolabe led ligand 
into the explant. This explanation seems untenable in t he 
epidermis where it is known t hat high M, particles and protein 
(horseradish peroxidase) rapidly permeate from t he dermis 
through to the upper layers of the epidermis [ 40,41 and refer-
ences t herein] . Also no ev idence for upper epidermal labeling 
is seen at the edge of explants where penetration into t he 
epidermis should be facile, and indeed, it is noteworthy that 
labeling in the hair bulb region is not entirely absent a round 
t he dermal papi ll a (Fig 2e,f), indicating that penetration of 
[ 12"1]EGF can occur in t hi s region. Finally, as t he epit heli a l 
tissues of t he epidermis and hair bulb have no direct vascular 
supply and receive nut rients passively from t he dermis it would 
be unlikely for [' 2"I]EGF to be specifically excluded from these 
t issues. 
A second interpretation is that EGF-Rl can recognize an 
antigenic determinant present on a protein unrelated to t he 
EGF receptor. This suggestion also seems very unlikely as our 
immunoprecipitation (Fig 5) and binding data (F ig 4c,d) show 
that EGF-Rl spec ifica lly recognizes t he EGF receptor on t he 
surface of a human epidermal cell line (SVK14). However thi s 
possibility may not be tota lly excluded as molecu les could be 
synt hes ized in the upper ep idermal layers and in the hair fo llicle 
bulb region which recognize EGF-Rl but a re not present on 
the surface of SVK14 cells. 
Thirdly, t he monoclona l ant ibody may be recognizing in tra-
ce llula r recepto rs which would therefore be inaccessible to 
exogenous [12''1]EGF. A proportion of these receptors might be 
occupied with a natura lly occurring ligand and have been 
inte rna lized by ligand-driven recepto r-mediated endocytosis. It 
is noteworthy that the EGF-Rl pattern arou nd the upper part 
of the dermal papilla (Fig 46) and to a lesser extent in the lower 
dermal papilla region (Fig 4a), is not clearly restricted to the 
ce ll margins, suggesting at least a partial intracellular loca li -
zation of immunoreactive receptor. Indeed our preliminary data 
on the ultrastructure loca li zation of EGF-Rl in t he hair bulb 
confirms some in t race llula r recogni t ion. Cytoplasmic EGF re-
cepto rs might a lso arise if recepto rs were not correctly t rans-
ported and in troduced in to the plasma cell membrane or redis-
t ribu ted in the absence of li gand to in t racellula r positions on 
differentiating ep ithelia l t issues. 
Lastly, EGF-R1 recogni tion in the abse nce of (12 r. I]EGF 
binding may arise from the presence of a modified EGF- recep-
to r, a ltered in such a way that it is unable to bind, or has a 
much reduced affinity for [12"I]EGF. In support of thi s hypoth-
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esis a ra n ge of agen ts s uch as phorbo l este rs, vasopressin , 
vitamin K., a nd p latelet-de rived g rowth factor a re known to 
reduce ce llula r [' 2"I]EGF binding by up to 90 % [3 a nd references 
t he re in]. P horbo l este rs act t hrough t he Ca2+, phospholipid -
dependent, se rine- a nd t hreonine-sp ecific protein kinase-C [ 42 ] 
which itself is kn own to phosp hory late a t hreo nine on the 
residue cytoplasmi c dom a in o f the EGF recepto r [43 ]. Inte rest-
ingly, a re lated prote in kin ase-C has rece nt ly bee n partly pur-
ified fro m pig ep ide rmi s [44]. Ce ll surface receptors may a lso 
be re ndered inact ive by structura l m odification. For example 
the data o f Fransson et a l [4 5] suggest that additi on of hepa ra n 
sulfate glycosa minoglyca n ch a ins to a tra n s fe rrin binding pro-
tein co re (a transferrin-receptor) m ay cau se t he molecule to 
lose its t ra n s fe rrin bindin g activity . G ive n that exte rn a l agents 
ca n reduce EGF receptor a ffini ty in v it ro a nd that receptors 
ca n be rendered inactive by structura l m odifi catio n , it is rea-
so nable to s uggest t hat the addit io na l EGF -Rl recogni t ion seen 
he re mi ght be due to the ex istence of structura lly m odified 
EGF recepto rs. 
In conclus ion , we have compared the [' 2'' I]EGF binding dis-
tr ibution and EGF-IU recognition profile in whole human scalp 
skin a nd fo reskin and discussed p ossible explanations for t he 
presence of EGF-Rl sta ining in the a bsence of EGF binding. 
H oweve r, in the li ght o f curre nt knowl edge, the most attractive 
interpretation is t hat a latent poo l of in t racellular a nd/o r 
structura lly modified EGF receptors ex ist in huma n skin. If 
t his co nclus ion is co rrect it wi ll h ave importa nt con sequen ces 
both for t he way t hat t issue EGF bindi n g data should be 
inte rpreted, a nd for t he physiologic ro le o f t he EGF receptor. 
It would a lso indicate that m ec ha ni sm s ex ist to e nable differ-
entiating epithelia l tissues to beco me unrespo n s ive to mitoge nic 
ligands by m odificatio n of ce ll surface receptors . Fu rt he r studies 
including e lectron mic roscopy a re in progress to clarify w hy 
EGF-Rl staining is found in the absence of EGF binding. 
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